The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
Open accessAbstract
Cyclin-dependent kinases (Cdks) are positive regulators of cell proliferation, whereas Cdk inhibitors (CKIs) inhibit proliferation. We describe a new CKI, p57KIP2, which is related to p21CIP1 and p27KIP1. p57KIP2 is a potent, tight-binding inhibitor of several G1 cyclin/Cdk complexes, and its binding is cyclin dependent. Unlike CIP1, KIP2 is not regulated by p53. Overexpression of p57KIP2 arrests cells in G1. p57KIP2 proteins have a complex structure. Mouse p57KIP2 consists of four structurally distinct domains: an amino-terminal Cdk inhibitory domain, a proline-rich domain, an acidic-repeat region, and a carboxy-terminal domain conserved with p27KIP1. Human p57KIP2 appears to have conserved the amino- and carboxy-terminal domains but has replaced the internal regions with sequences containing proline-alanine repeats. In situ hybridization during mouse embryogenesis revealed that KIP2 mRNA displays a striking pattern of expression during development, showing high level expression in skeletal muscle, brain, heart, lungs, and eye. Most of the KIP2-expressing cells are terminally differentiated, suggesting that p57KIP2 is involved in decisions to exit the cell cycle during development and differentiation. Human KIP2 is located at 11p15.5, a region implicated in both sporadic cancers and Beckwith-Wiedemann syndrome, a familial cancer syndrome, marking it as a candidate tumor suppressor. The discovery of a new member of the p21CIP1 inhibitor family with novel structural features and expression patterns suggests a complex role for these proteins in cell cycle control and development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,336
Self-citationPolyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Cited by
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Self-citationNakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,251
CDK inhibitors: Cell cycle regulators and beyond
Besson, A., Dowdy, S. F., & Roberts, J. M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.013 · Cited by 1,152
Treating cancer with selective CDK4/6 inhibitors
O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137
Flexible nets: The roles of intrinsic disorder in protein interaction networks
Dunker, A. K., Cortese, M. S., Romero, P., Iakoucheva, L. M., & Uversky, V. N. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04948.x · Cited by 1,122
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir, I., Polyak, K., Iavarone, A., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.15.1831 · Cited by 962
Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex
Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J., & Pavletich, N. P. (1996) · Nature · doi:10.1038/382325a0 · Cited by 907
Liu, M., Lee, M. H., Cohen, M., Bommakanti, M., & Freedman, L. P. (1996) · Genes & Development · doi:10.1101/gad.10.2.142 · Cited by 890
Translational Control of p27 Kip1 Accumulation During the Cell Cycle
Hengst, L., & Reed, S. I. (1996) · Science · doi:10.1126/science.271.5257.1861 · Cited by 846
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Zhang, P., Liégeois, N. J., Wong, C., Finegold, M., Hou, H., Thompson, J. C., Silverman, A., Harper, J. W., DePinho, R. A., & Elledge, S. J. (1997) · Nature · doi:10.1038/387151a0 · Cited by 749
Self-citationNiculescu, A. B., Chen, X., Smeets, M., Hengst, L., Prives, C., & Reed, S. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.629 · Cited by 724
CYCLINS AND CELL CYCLE CHECKPOINTS
Johnson, D. G., & Walker, C. L. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.295 · Cited by 719
Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1
Vlach, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5334 · Cited by 688
Requirement of p27 Kip1 for Restriction Point Control of the Fibroblast Cell Cycle
Coats, S., Flanagan, W. M., Nourse, J., & Roberts, J. M. (1996) · Science · doi:10.1126/science.272.5263.877 · Cited by 679
Transcriptional Regulation of the p21(WAF1/CIP1)Gene
Gartel, A. L., & Tyner, A. L. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4319 · Cited by 664
Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1
Tomoda, K., Kubota, Y., & Kato, J.-Y. (1999) · Nature · doi:10.1038/18230 · Cited by 632
Lloyd, R. V., Erickson, L. A., Jin, L., Kulig, E., Qian, X., Cheville, J. C., & Scheithauer, B. W. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65277-7 · Cited by 593
Kriwacki, R. W., Hengst, L., Tennant, L., Reed, S. I., & Wright, P. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11504 · Cited by 575
Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration
Ahuja, P., Sdek, P., & MacLellan, W. R. (2007) · Physiological Reviews · doi:10.1152/physrev.00032.2006 · Cited by 568
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
Luo, Y., Hurwitz, J., & Massagué, J. (1995) · Nature · doi:10.1038/375159a0 · Cited by 549
Shackelford, R. E., Kaufmann, W. K., & Paules, R. S. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00224-0 · Cited by 524
Yan, Y., Frisén, J., Lee, M. H., Massagué, J., & Barbacid, M. (1997) · Genes & Development · doi:10.1101/gad.11.8.973 · Cited by 493
p21 and p27: roles in carcinogenesis and drug resistance
Abukhdeir, A. M., & Park, B. H. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000744 · Cited by 463
Zhu, X., Ohtsubo, M., Böhmer, R. M., Roberts, J. M., & Assoian, R. K. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.2.391 · Cited by 453
Robker, R. L., & Richards, J. S. (1998) · Molecular Endocrinology · doi:10.1210/me.12.7.924 · Cited by 451
Control of Müller glial cell proliferation and activation following retinal injury
Dyer, M. A., & Cepko, C. L. (2000) · Nature Neuroscience · doi:10.1038/78774 · Cited by 442
Cell-cycle inhibitors: three families united by a common cause
Vidal, A., & Koff, A. (2000) · Gene · doi:10.1016/s0378-1119(00)00092-5 · Cited by 431
Aktas, H., Cai, H., & Cooper, G. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3850 · Cited by 410
Peles, E., Nativ, M., Lustig, M., Grumet, M., Schilling, J., Martinez, R., Plowman, G. D., & Schlessinger, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.978 · Cited by 400
Cdk inhibitors in development and cancer
Wade Harper, J., & Elledge, S. J. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)90011-8 · Cited by 399
Self-citationNF-κB and cell-cycle regulation: the cyclin connection
JOYCE, D., ALBANESE, C., STEER, J., FU, M., BOUZAHZAH, B., & PESTELL, R. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00018-6 · Cited by 393
Developmental Control of Cell Cycle Regulators: A Fly's Perspective
Edgar, B. A., & Lehner, C. F. (1996) · Science · doi:10.1126/science.274.5293.1646 · Cited by 388
Cell cycle checkpoints and their inactivation in human cancer
Molinari, M. (2000) · Cell Proliferation · doi:10.1046/j.1365-2184.2000.00191.x · Cited by 388
Timchenko, N. A., Wilde, M., Nakanishi, M., Smith, J. R., & Darlington, G. J. (1996) · Genes & Development · doi:10.1101/gad.10.7.804 · Cited by 387
An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome
Hatada, I., Ohashi, H., Fukushima, Y., Kaneko, Y., Inoue, M., Komoto, Y., Okada, A., Ohishi, S., Nabetani, A., Morisaki, H., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-171 · Cited by 382
Pestell, R. G., Albanese, C., Reutens, A. T., Segall, J. E., Lee, R. J., & Arnold, A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0373 · Cited by 375
Ma, T., Van Tine, B. A., Wei, Y., Garrett, M. D., Nelson, D., Adams, P. D., Wang, J., Qin, J., Chow, L. T., & Harper, J. W. (2000) · Genes & Development · doi:10.1101/gad.829500 · Cited by 372
Self-citationKassem, S. A., Ariel, I., Thornton, P. S., Scheimberg, I., & Glaser, B. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1325 · Cited by 361
Gene disruption of p27 Kip1 allows cell proliferation in the postnatal and adult organ of Corti
Löwenheim, H., Furness, D. N., Kil, J., Zinn, C., Gültig, K., Fero, M. L., Frost, D., Gummer, A. W., Roberts, J. M., Rubel, E. W., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.4084 · Cited by 361
p57 is required for quiescence and maintenance of adult hematopoietic stem cells
Matsumoto, A., Takeishi, S., Kanie, T., Susaki, E., Onoyama, I., Tateishi, Y., Nakayama, K., & Nakayama, K. I. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.06.014 · Cited by 329
Dacapo, a Cyclin-Dependent Kinase Inhibitor, Stops Cell Proliferation during Drosophila Development
Lane, M. E., Sauer, K., Wallace, K., Jan, Y. N., Lehner, C. F., & Vaessin, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81818-8 · Cited by 327
Cell cycle exit upon myogenic differentiation
Walsh, K., & Perlman, H. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80005-6 · Cited by 325
Durand, B. (1997) · The EMBO Journal · doi:10.1093/emboj/16.2.306 · Cited by 325
Cyclin-Binding Motifs Are Essential for the Function of p21 CIP1
Chen, J., Saha, P., Kornbluth, S., Dynlacht, B. D., & Dutta, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4673 · Cited by 320
de Nooij, J. C., Letendre, M. A., & Hariharan, I. K. (1996) · Cell · doi:10.1016/s0092-8674(00)81819-x · Cited by 318
Physiological functions of imprinted genes
Tycko, B., & Morison, I. M. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10129 · Cited by 315
Zhang, P., Wong, C., DePinho, R. A., Harper, J. W., & Elledge, S. J. (1998) · Genes & Development · doi:10.1101/gad.12.20.3162 · Cited by 309
Self-citationde Lonlay, P., Fournet, J. C., Rahier, J., Gross-Morand, M. S., Poggi-Travert, F., Foussier, V, Bonnefont, J. P., Brusset, M. C., Brunelle, F., Robert, J. J., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119594 · Cited by 306
Lacy, E. R., Filippov, I., Lewis, W. S., Otieno, S., Xiao, L., Weiss, S., Hengst, L., & Kriwacki, R. W. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb746 · Cited by 305
Laronga, C., Yang, H.-Y., Neal, C., & Lee, M.-H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m905616199 · Cited by 304
Matsuoka, S., Thompson, J. S., Edwards, M. C., Bartletta, J. M., Grundy, P., Kalikin, L. M., Harper, J. W., Elledge, S. J., & Feinberg, A. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.3026 · Cited by 301
Self-citationChoufani, S., Shuman, C., & Weksberg, R. (2010) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30267 · Cited by 301
Cordon-Cardo, C., Koff, A., Drobnjak, M., Capodieci, P., Osman, I., Millard, S. S., Gaudin, P. B., Fazzari, M., Zhang, Z.-F., Massague, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.17.1284 · Cited by 300
Degradation of p57 Kip2 mediated by SCF Skp2 -dependent ubiquitylation
Kamura, T., Hara, T., Kotoshiba, S., Yada, M., Ishida, N., Imaki, H., Hatakeyama, S., Nakayama, K., & Nakayama, K. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1831009100 · Cited by 292
Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development
Weksberg, R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg067 · Cited by 291
Brooks, A. R., Lelkes, P. I., & Rubanyi, G. M. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00075.2001 · Cited by 291
Verkarre, V, Fournet, J. C., de Lonlay, P., Gross-Morand, M. S., Devillers, M., Rahier, J., Brunelle, F., Robert, J. J., Nihoul-Fékété, C., Saudubray, J. M., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4495 · Cited by 290
Genomic imprinting of p57KIP2, a cyclin–dependent kinase inhibitor, in mouse
Hatada, I., & Mukai, T. (1995) · Nature Genetics · doi:10.1038/ng1095-204 · Cited by 287
Cyclin dependent kinase regulation
Lees, E. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80060-3 · Cited by 285
Blain, S. W., Montalvo, E., & Massagué, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25863 · Cited by 279
Megyesi, J., Safirstein, R. L., & Price, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1497 · Cited by 272
Adrenocortical cancer: pathophysiology and clinical management
Libè, R., Fratticci, A., & Bertherat, J. (2007) · Endocrine-Related Cancer · doi:10.1677/erc.1.01130 · Cited by 272
The diverse functions of Krüppel‐like factors 4 and 5 in epithelial biology and pathobiology
McConnell, B. B., Ghaleb, A. M., Nandan, M. O., & Yang, V. W. (2007) · BioEssays · doi:10.1002/bies.20581 · Cited by 258
Cell cycle control, checkpoint mechanisms, and genotoxic stress.
Shackelford, R. E., Kaufmann, W. K., & Paules, R. S. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107s15 · Cited by 257
Scandura, J. M., Boccuni, P., Massagué, J., & Nimer, S. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406771101 · Cited by 254
Matsusaka, K., Kaneda, A., Nagae, G., Ushiku, T., Kikuchi, Y., Hino, R., Uozaki, H., Seto, Y., Takada, K., Aburatani, H., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1349 · Cited by 254
p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.
Zhu, L., Harlow, E., & Dynlacht, B. D. (1995) · Genes & Development · doi:10.1101/gad.9.14.1740 · Cited by 252
McConnell, B. B., Gregory, F. J., Stott, F. J., Hara, E., & Peters, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1981 · Cited by 238
Wu, H., Wade, M., Krall, L., Grisham, J., Xiong, Y., & Van Dyke, T. (1996) · Genes & Development · doi:10.1101/gad.10.3.245 · Cited by 234
Pop, R., Shearstone, J. R., Shen, Q., Liu, Y., Hallstrom, K., Koulnis, M., Gribnau, J., & Socolovsky, M. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000484 · Cited by 179
“30-fold decrease in the CDKI p57 mRNA, but no significant change in the mRNA of other members of the CIP/KIP CDKI family; there was induction in p27 later in differentiation, in subsets S2 and S3 (Figure 1G and Figure S1F) [22,23].”
BackgroundParry, D., Mahony, D., Wills, K., & Lees, E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1775 · Cited by 174
Stewart, Z. A., Leach, S. D., & Pietenpol, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.205 · Cited by 168
Molecular genetics of adrenocortical tumours, from familial to sporadic diseases
Libé, R., & Bertherat, J. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02004 · Cited by 168
Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure
Megyesi, J., Andrade, L., Vieira, J. M., Safirstein, R. L., & Price, P. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00044.x · Cited by 153
Cross-talk between protein kinase C and multifunctional Ca2+/calmodulin-dependent protein kinase.
MacNicol, M., & Schulman, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49824-4 · Cited by 131
Analysis of Wild-Type and Mutant p21 WAF-1 Gene Activities
Lin, J., Reichner, C., Wu, X., & J. Levine, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1786 · Cited by 111
Asahara, S.-I., Etoh, H., Inoue, H., Teruyama, K., Shibutani, Y., Ihara, Y., Kawada, Y., Bartolome, A., Hashimoto, N., Matsuda, T., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422104112 · Cited by 63
Van de Pette, M., Abbas, A., Feytout, A., McNamara, G., Bruno, L., To, W. K., Dimond, A., Sardini, A., Webster, Z., McGinty, J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.010 · Cited by 55
Ye, W., Mairet‐Coello, G., Pasoreck, E., & DiCicco‐Bloom, E. (2009) · Developmental Neurobiology · doi:10.1002/dneu.20680 · Cited by 43
Pedroza-Saavedra, A., Lam, E. W.-F., Esquivel-Guadarrama, F., & Gutierrez-Xicotencatl, L. (2010) · Virology · doi:10.1016/j.virol.2010.01.009 · Cited by 39
Genome-wide expression profiling of placentas in the p57Kip2 model of pre-eclampsia
Knox, K. S., & Baker, J. C. (2007) · MHR: Basic science of reproductive medicine · doi:10.1093/molehr/gal116 · Cited by 33
Xie, P., Wang, H., Xie, J., Huang, Z., Chen, S., Cheng, X., Zhang, X., Liu, F., Li, Y., & Huang, D. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111037 · Cited by 16
Metadata
- Authors
- Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., & Elledge, S. J.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1995-03-15
- Volume
- 9
- Issue
- 6
- Pages
- 650-662
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2055085859
- Cited by
- 952
- References
- 49
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.